<DOC>
	<DOCNO>NCT01127035</DOCNO>
	<brief_summary>Respiratory allergy due Alternaria relevant clinical problem , specific immunotherapy may represent viable treatment option . Sublingual immunotherapy ( SLIT ) safe effective , data Alternaria lacking . The study aim assess efficacy standardized SLIT patient sensitise Alternaria , randomize , double blind , placebo control fashion . Patients rhinitis with/without intermittent asthma , ascertain allergy Alternaria enrol . After baseline season , SLIT match placebo give 10 month . Symptoms rescue medication intake record diary card June October . Skin prick test , specific IgE IgG4 precipitins measure baseline end study . Alternaria spore count also perform . Primary outcome change symptom score active v placebo group . Secondary outcome : change rescue medication intake , alternaria specific IgE IgG4 , skin prick test reactivity .</brief_summary>
	<brief_title>Sublingual Immunotherapy In Alternaria-Induced Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Allergic rhinitis Symptoms MayOctober Specific IgE alternaria ( skin test/radioallergosorbent [ RAST ] test ) Age &gt; 14 Sensitization mite , parietaria , mugwort Pregnancylactation Malignancies Chronic systemic steroid Previous immunotherapy alternaria</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>allergic rhinitis</keyword>
	<keyword>alternaria alternata</keyword>
	<keyword>symptom score</keyword>
</DOC>